Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Milk is the source of high-quality protein, calcium, and other vitamins and minerals. Epidemiologic studies have linked high consumption of milk with risk of metabolic syndrome, T2DM, hypertension and obesity, which are independent risk factors of cardiovascular disease. However, milk contains disaccharide lactose, which may cause gastrointestinal problems in those adults with poor digestion. Recent studies have shown that subjects with intolerance to lactose tend to reduce their consumption of milk. Actually, consumption of 12g lactose (240ml milk) per day produces negligible symptoms in lactose intolerant. Furthermore, a dairy-rich diet could improve lactose intolerance because of colonic adaption to it. Lactose maldigestion would not be a restricting factor in milk intake. In general, the undigested lactose will be fermented by colonic bacteria into hydrogen, carbon dioxide, and short-chain fatty acids (SCFA: acetate, propionate, and butyrate). The SCFAs may have beneficial effects on human glucose and lipid metabolism, and the lactose fermentation may change the intestinal flora profile. But there are few studies evaluating effect of milk intake on health of people with lactose malabsorption or intolerance.This trial intend to study the effect of whole milk on cardio-metabolic risk factors of healthy person with or without lactose maldigestion.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| lactose digesters | Active Comparator | Participants in arm 1 are grouped as lactose digesters based on breath hydrogen test after a 25-g lactose load. The breath hydrogen excretion is less than 20 ppm. |
|
| lactose maldigesters | Active Comparator | Participants in arm 2 are also grouped as lactose maldigesters based on breath hydrogen test after a 25-g lactose load. The breath hydrogen excretion is not less than 20 ppm. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| full-fat milk | Dietary Supplement | intake 250ml full-fat milk per day, do not intake any other dairy products |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes in body weight | 4 weeks | |
| Change in body composition (body fat mass and lean mass) | Body fat mass and lean mass measured by Bioelectric Impedance Analysis(BIA) | 4 weeks |
| Changes in blood pressure | Systolic Blood Pressure and Diastolic Blood Pressure before and after milk intervention | 4 weeks |
| Changes in blood lipids profile | Fasting plasma Total cholesterol, Low Density Lipoprotein, High Density Lipoprotein and triglycerides before and after milk intervention | 4 weeks |
| Changes in fasting plasma glucose | 4 weeks | |
| Changes in fasting plasma insulin | 4 weeks | |
| Changes in fasting plasma C-peptide | 4 weeks | |
| Changes in Homeostasis Model Assessment of Insulin Resistance(HOMA-IR) | Insulin sensitivity measure derived from fasting glucose and insulin | 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in pro-inflammatory markers | Fasting plasma C-reactive protein, interleukin-6 and tumor necrosis factor-α before and after milk intervention | 4 weeks |
| Changes in markers of oxidative stress |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Liegang Liu, PhD | Contact | +86-27-83650522 | liegangliu@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Liegang Liu, PhD | Huazhong University of Science and Technology | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Huazhong University of Science and Technology | Recruiting | Wuhan | Hubei | 430030 | China |
| Type | Date | Date Unknown |
|---|---|---|
| Release | Jun 10, 2018 | |
| Unrelease | Aug 31, 2018 | |
| Release | Aug 31, 2018 | |
| Reset | Feb 1, 2019 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jun 10, 2018 | Aug 31, 2018 | |||
| Aug 31, 2018 |
| ID | Term |
|---|---|
| D007787 | Lactose Intolerance |
| D002318 | Cardiovascular Diseases |
| ID | Term |
|---|---|
| D008286 | Malabsorption Syndromes |
| D007410 | Intestinal Diseases |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Fasting plasma MDA, oxidized LDL before and after milk intervention
| 4 weeks |
| Biomarkers in urine | 4 weeks |
| Changes in fecal fat excretion | 4 weeks |
| Changes in fecal short chain fatty acids (SCFA) | Fecal acetate, propionate, butyrate before and after milk intervention | 4 weeks |
| Feb 1, 2019 |
| D002239 | Carbohydrate Metabolism, Inborn Errors |
| D008661 | Metabolism, Inborn Errors |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |